(1) Changes in recommendations and levels of evidence were made either because of new
randomized trials or because of the accumulation of new clinical evidence and the …

The implantable cardioverter-defibrillator (ICD) is remarkably effective in preventing sudden
cardiac death in high-risk patients, but it also has the capacity to provoke or worsen cardiac …

Objectives: The purpose of this study was to determine the mechanisms of sudden death
(SD) in patients with ventricular tachyarrhythmias (ventricular tachycardia/ventricular …

Background The purpose of the present report was to document clinical experience derived
from the implantation of 2834 epicardial and endocardial cardioverter-defibrillators (ICDs) in …

Appropriate and inappropriate therapies of implantable cardioverter defibrillators have a
major impact on morbidity and quality of life in ICD recipients, but have not been …

BACKGROUND Implantable transvenous cardioverter-defibrillators offer a significant
opportunity to decrease procedural morbidity and medical costs in the care of patients with …

Background—Implantable cardioverter-defibrillators (ICDs) reduce the risk of sudden
cardiac death. The objective of this study was to evaluate whether testing of antitachycardia …

Exenatide has been widely used for the treatment of type 2 diabetes mellitus. However, its
short plasma half-life of 2.4 hours has limited its clinical application. The exenatide products …

OBJECTIVES.: The purpose of this study was to prospectively examine in a multicenter study
the methods of use, efficacy and complications of a unipolar cardioverter-defibrillator in …

Background This study examines the limitations and complex management problems
associated with the use of tiered-therapy, implantable cardioverter-defibrillators (ICDs) …